Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pirus Ghadjar

Showing results (91-100 of 187) with videos related to

Pageof 19
Sort By:
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|April 11, 2016
Volumetric regression ratio of the primary tumor and metastatic lymph nodes after induction chemotherapy predicts overall survival in head and neck squamous cell carcinoma: a retrospective analysisOlgun Elicin, Michael Schmucking, Jens Bromme, et al.
Orthopadie (Heidelberg, Germany)|July 13, 2026
[Surgical treatment options for soft tissue sarcomas : Indications, diagnostics, techniques, and limitations]Silvan Wittenberg, Anne Flörcken, Franziska Borchert, et al.
Radiation Oncology (London, England)|October 22, 2008
Acute and late toxicity in prostate cancer patients treated by dose escalated intensity modulated radiation therapy and organ trackingPirus Ghadjar, Jacqueline Vock, Daniel Vetterli, et al.
International Journal of Radiation Oncology, Biology, Physics|November 28, 2012
Prognostic importance of Gleason 7 disease among patients treated with external beam radiation therapy for prostate cancer: results of a detailed biopsy core analysisDaniel E Spratt, Zach Zumsteg, Pirus Ghadjar, et al.
Radiation Oncology (London, England)|September 4, 2019
Adjuvant radiotherapy improves progression-free survival in intracranial atypical meningiomaSaman Moritz Hemmati, Pirus Ghadjar, Arne Grün, et al.
International Journal of Radiation Oncology, Biology, Physics|February 12, 2015
Hyperfractionated accelerated radiation therapy (HART) of 70.6 Gy with concurrent 5-FU/Mitomycin C is superior to HART of 77.6 Gy alone in locally advanced head and neck cancer: long-term results of the ARO 95-06 randomized phase III trialVolker Budach, Carmen Stromberger, Christoph Poettgen, et al.
Radiation Oncology (London, England)|September 23, 2015
Thermal magnetic resonance: physics considerations and electromagnetic field simulations up to 23.5 Tesla (1GHz)Lukas Winter, Celal Oezerdem, Werner Hoffmann, et al.
Plos One|October 13, 2017
Dose-escalated radiotherapy for unresectable or locally recurrent pancreatic cancer: Dose volume analysis, toxicity and outcome of 28 consecutive patientsSebastian Zschaeck, Bibiana Blümke, Peter Wust, et al.
Bioengineering (Basel, Switzerland)|July 27, 2024
Helmet Radio Frequency Phased Array Applicators Enhance Thermal Magnetic Resonance of Brain TumorsFaezeh Rahimi, Bilguun Nurzed, Thomas W Eigentler, et al.
BJU International|January 23, 2014
Comparison of high-dose (86.4 Gy) IMRT vs combined brachytherapy plus IMRT for intermediate-risk prostate cancerDaniel E Spratt, Zachary S Zumsteg, Pirus Ghadjar, et al.
Pageof 19

Showing results (91-100 of 187) with videos related to

Sort By:
Pageof 19
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|April 11, 2016
Volumetric regression ratio of the primary tumor and metastatic lymph nodes after induction chemotherapy predicts overall survival in head and neck squamous cell carcinoma: a retrospective analysisOlgun Elicin, Michael Schmucking, Jens Bromme, et al.
Orthopadie (Heidelberg, Germany)|July 13, 2026
[Surgical treatment options for soft tissue sarcomas : Indications, diagnostics, techniques, and limitations]Silvan Wittenberg, Anne Flörcken, Franziska Borchert, et al.
Radiation Oncology (London, England)|October 22, 2008
Acute and late toxicity in prostate cancer patients treated by dose escalated intensity modulated radiation therapy and organ trackingPirus Ghadjar, Jacqueline Vock, Daniel Vetterli, et al.
International Journal of Radiation Oncology, Biology, Physics|November 28, 2012
Prognostic importance of Gleason 7 disease among patients treated with external beam radiation therapy for prostate cancer: results of a detailed biopsy core analysisDaniel E Spratt, Zach Zumsteg, Pirus Ghadjar, et al.
Radiation Oncology (London, England)|September 4, 2019
Adjuvant radiotherapy improves progression-free survival in intracranial atypical meningiomaSaman Moritz Hemmati, Pirus Ghadjar, Arne Grün, et al.
International Journal of Radiation Oncology, Biology, Physics|February 12, 2015
Hyperfractionated accelerated radiation therapy (HART) of 70.6 Gy with concurrent 5-FU/Mitomycin C is superior to HART of 77.6 Gy alone in locally advanced head and neck cancer: long-term results of the ARO 95-06 randomized phase III trialVolker Budach, Carmen Stromberger, Christoph Poettgen, et al.
Radiation Oncology (London, England)|September 23, 2015
Thermal magnetic resonance: physics considerations and electromagnetic field simulations up to 23.5 Tesla (1GHz)Lukas Winter, Celal Oezerdem, Werner Hoffmann, et al.
Plos One|October 13, 2017
Dose-escalated radiotherapy for unresectable or locally recurrent pancreatic cancer: Dose volume analysis, toxicity and outcome of 28 consecutive patientsSebastian Zschaeck, Bibiana Blümke, Peter Wust, et al.
Bioengineering (Basel, Switzerland)|July 27, 2024
Helmet Radio Frequency Phased Array Applicators Enhance Thermal Magnetic Resonance of Brain TumorsFaezeh Rahimi, Bilguun Nurzed, Thomas W Eigentler, et al.
BJU International|January 23, 2014
Comparison of high-dose (86.4 Gy) IMRT vs combined brachytherapy plus IMRT for intermediate-risk prostate cancerDaniel E Spratt, Zachary S Zumsteg, Pirus Ghadjar, et al.
Pageof 19